Kainever

Estazolam, the active ingredient in Kainever, is a benzodiazepine presented as an oral tablet for oral use. It is used to manage insomnia and anxiety disorders in adult patients.

GNH USA supplies Kainever as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Estazolam is indicated for conditions involving the central nervous system where sedation or anxiolysis is required. - Insomnia: helps initiate and maintain sleep, improving overall sleep quality. - Anxiety disorders: reduces excessive worry and tension, providing symptomatic relief. - Pre‑operative anxiety: offers short‑term calming effect before medical procedures.

Estazolam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness: feeling of sleepiness during daytime. - Dizziness: sensation of light‑headedness or imbalance. - Impaired coordination: reduced motor control and steadiness. - Memory disturbances: difficulty recalling recent events. - Headache: mild to moderate cranial pain.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, especially with high doses. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Paradoxical aggression: unexpected agitation or hostility. - Dependence or withdrawal: physical or psychological reliance after prolonged use. - Mood changes: depression or suicidal thoughts.

When prescribing Estazolam, clinicians should consider several safety precautions to minimize risks. - Assess patient history: evaluate prior benzodiazepine use, substance abuse, or psychiatric conditions. - Use lowest effective dose: start with the minimal dose needed for therapeutic effect. - Limit duration: restrict use to short‑term periods to avoid dependence. - Avoid abrupt discontinuation: taper gradually under medical supervision. - Caution in elderly: increased sensitivity to sedation and fall risk. - Store at ambient temperature: keep in original container, protect from moisture and light.

Estazolam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Opioids: combined use may cause profound respiratory depression. - CNS depressants: alcohol, barbiturates, or antihistamines increase sedation risk. - Antifungal agents (e.g., ketoconazole): may raise estazolam plasma levels.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may enhance central nervous system effects. - Anticonvulsants (e.g., carbamazepine): may reduce estazolam concentrations. - CYP3A4 inhibitors (e.g., erythromycin): can modestly increase drug exposure.